Cairo University
Cairo, Egypt
NCT Number: NCT04834245
Background: The wound dressings perform a crucial role in the cutaneous wounds' management due to their ability to protect wounds and promote dermal and epidermal tissue regeneration. Objective: the aim of the present study to evaluate the effectiveness of using hydrogel/nano silver-based dressing vs. traditional dressing on diabetic foot wound healing.
Approach: Sixty patients with type-2 diabetes hospitalized for diabetic foot wound treatment were recruited from selected Surgical departments at Kasr Al-Aini university hospital.
Looking for future studies?
Notify Me35 year–55 year
All sexes
Interventional
Not applicable
Cairo, Egypt
Data Collection: The patients of group-I wounds were cleaned using normal saline; then, the wounds were closed firmly with hyderogel\\nano silver dressing. The dressing was changed every two days according to dressing manufacture instruction. When the dressing was opened after three days, the wound was assessed for granulation tissue, wound, and discharge size.
The patients of group II wounds were dresses using a traditional method, cleaned by normal saline, use of betadine antiseptic; then they were secured with clean linen gauze. The dressing was changed once daily. The wound healing process of the two groups was then assessed for three consecutive weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Diabetes Type I and Type II patient with diabetic foot ulcer age ranged 35-55 years old Willing to participate
Exclusion criteria
unwilling to participate.
compare the effectiveness of using hydrogel/nano silver-based dressing vs. traditional dressing on diabetic foot wound healing.
Time frame: 3 Weeks
assess of diabetic foot ulcers size "sq mm"
Magda Bayoumi
Other
Evaluation of Diabetic Foot Wound Healing Using Hydrogel/Nano Silver-based Dressing vs. Traditional Dressing: A Prospective Randomized Control Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05189470
Cardiovascular Diseases, Diabetes
Herlev, Denmark
View Trial DetailsNCT06569238
Cardiovascular Diseases, Diabetes Complications
Ann Arbor, Michigan, United States
View Trial DetailsNCT06518486
Cardiovascular Diseases, Diabetes
Batang, Central Java, Indonesia
View Trial DetailsNCT07084922
Cardiovascular Diseases, Diabetes Complications
Istanbul, Turkey (Türkiye)
View Trial Details